ArticleInternational journal of exercise science2025
Incidence and Risk Factors of Metabolic Syndrome in Track and Field Throwing Athletes.
Article in International journal of exercise science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Track and field (T&F) throwers are a prominent subgroup of athletes that may be at risk for the development of Metabolic Syndrome (MetSyn) and other cardiometabolic disease conditions. However, limited research exists examining the prevalence of MetSyn in these athletes. Therefore, the purpose of this study was to examine the incidence of MetSyn and associated risk factors in collegiate throwers. Collegiate Division I men (n=17) and women (n=4) T&F throwers participated in a single day of lab assessments, which included anthropometrics, body composition, blood pressure, a venous blood draw, and aerobic capacity. MetSyn was diagnosed based on the following clinical markers: HDL, triglycerides, glucose, waist circumference, and blood pressure. MetSyn was present in 47% of men and 0% of women athletes. The most common risk factors were excessive waist circumference (men: 65%, women: 25%), reduced HDL (men: 59%, women: 50%), and elevated systolic blood pressure (men: 47%, women: 25%). BF% was associated with SBP (r=0.71), DBP (r=0.74), insulin (r=0.58), insulin resistance (r=0.58), triglycerides (r=0.51), and VO
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.